CE / CME
Hear from global experts Ann Avery, MD; Isolde Butler, MD, MPH; Monica Gandhi, MD, MPH; Marissa Gonzalez; Angelina Namiba; and Miłosz Parczewski, MD, PhD, on how innovative models of care are minimizing barriers to HIV care engagement to improve uptake by key underserved populations.
Nurses: 0.75 Nursing contact hour
Physicians: maximum of 0.75 AMA PRA Category 1 Credit™
Pharmacists: 0.75 contact hour (0.075 CEUs)
Released: November 01, 2023
Expiration: October 31, 2024
Share
Ann Avery, MD
Professor of Medicine
Case Western Reserve University
Division of Infectious Diseases
MetroHealth Medical Center
Cleveland, Ohio
Jennifer Blanchette, PhD
Independent Contractor
Clinical Care Options
Colorado, United States
Isolde F. Butler, MD, MPH
Chief Medical Officer
Crescent Care
New Orleans, Louisiana
Monica Gandhi, MD, MPH
Professor of Medicine
Associate Chief, Division of HIV, Infectious Diseases and Global Medicine
Director, Center for AIDS Research
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California
Marissa Gonzalez
Chair
Community Advisory Board
The Well Project
Angelina Namiba
Patient Advocate/Project Manager
4M Network of Mentor Mothers Living With HIV
London, United Kingdom
Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom
Milosz Parczewski, MD, PhD
Professor of Medicine
Consultant Physician, ID Specialist
Head
Department of Infectious, Tropical Diseases and Immune Deficiency
Pomeranian Medical University
Szczecin, Poland
Provided by Clinical Care Options, LLC
Supported by an educational grant from Gilead Sciences, Inc.
Gilead Sciences, Inc.
This program is intended for physicians, pharmacists, registered nurses, physician associates, and other healthcare professionals who care for persons with HIV.
The goal of this program is to improve learners’ knowledge and competence regarding the evolving field of HIV care including current best practices in HIV service delivery, the potential role of emerging ART options, and key concepts in HIV cure research.
Upon completion of this activity, participants should be able to:
Improve HIV care delivery by applying insights from settings that are successfully minimizing barriers to ART uptake among disadvantaged groups of people living with HIV
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Primary Author
Ann Avery, MD
Professor of Medicine
Case Western Reserve University
Division of Infectious Diseases
MetroHealth Medical Center
Cleveland, Ohio
Ann Avery, MD, has no relevant financial relationships to disclose.
Jennifer Blanchette, PhD
Independent Contractor
Clinical Care Options
Colorado, United States
Jennifer Blanchette, PhD, has no relevant financial relationships to disclose.
Isolde F. Butler, MD, MPH
Chief Medical Officer
Crescent Care
New Orleans, Louisiana
Isolde Butler, MD, MPH, has no relevant financial relationships to disclose.
Monica Gandhi, MD, MPH
Professor of Medicine
Associate Chief, Division of HIV, Infectious Diseases and Global Medicine
Director, Center for AIDS Research
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco
San Francisco, California
Monica Gandhi, MD, MPH, has no relevant financial relationships to disclose.
Marissa Gonzalez,
Chair
Community Advisory Board
The Well Project
Marissa Gonzalez has no relevant financial relationships to disclose.
Angelina Namiba,
Patient Advocate/Project Manager
4M Network of Mentor Mothers Living With HIV
London, United Kingdom
Angelina Namiba has no relevant financial relationships to disclose.
Chloe Orkin, MBChB, FRCP, MD
Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Honorary Consultant Physician
Barts Health NHS Trust
London, United Kingdom
Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GSK, Merck Sharp & Dohme, ViiV.
Milosz Parczewski, MD, PhD
Professor of Medicine
Consultant Physician, ID Specialist
Head
Department of Infectious, Tropical Diseases and Immune Deficiency
Pomeranian Medical University
Szczecin, Poland
Milosz Parczewski, MD, PhD: consultant/advisor/speaker: Gilead Sciences, Janssen, Merck Sharp & Dohme, Roche, ViiV/GlaxoSmithKline; fees for non-CME/CE services: Gilead Sciences, Janssen, MSD.
The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose.
Participation in this self-study activity should be completed in approximately 0.75 hour. To successfully complete this activity and receive credit, participants must follow these steps during the period from November 01, 2023, through October 31, 2024:
Login or Sign Up for an account by clicking at the top of this page.
Read the target audience, learning objectives, and faculty disclosures.
View and study the content in its entirety.
After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.
This program has been made available online.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.75 contact hours.
Continuing Pharmacy Education
CCO designates this continuing education activity for 0.75 contact hours (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-23-278-H02-P
Type of Activity: Knowledge
Upon successfully completing the post-test with a score of 65% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.